Rincon Bio performs MDA-MB-231 xenograft models to test efficacy of preclinical therapies. Please see below for additional information or to request a quote.
MDA-MB-231 cells were isolated from a 51 year old female with adenocarcinoma of the breast.
Forms tumors in nude and BALB/c mice
Used in xenografts to test the efficacy of novel cancer therapeutics
Rincon Bio Growth Curve
MDA-MB-231 cells implanted in nude mice
WHY WORK WITH
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
Most efficacy studies can be initiated within two business days.
We love our clients! We are easy to work with. And we take a personal interest in our clients and their studies.